What role do cannabinoids play in modulating inflammation in autoimmune disorders?
What role do cannabinoids play in modulating inflammation in autoimmune disorders? Cannabinoids play a significant role in modulating inflammation in autoimmune disorders by interacting with the endocannabinoid system to regulate immune responses. Research indicates that cannabinoids, particularly CBD and CBG, can exert anti-inflammatory effects by inhibiting pro-inflammatory cytokine release and promoting the resolution of inflammation. This modulation may help alleviate symptoms and prevent disease progression in conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. Additionally, cannabinoids may improve immune tolerance and reduce tissue damage, further supporting their therapeutic potential in autoimmune disorders. As understanding of cannabinoid actions expands, they may become valuable tools in managing inflammation-related conditions (Rudroff et al., 2018).